EAST RUTHERFORD, N.J., Feb. 08, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), and finished dosage forms, today announced that fourth quarter and full year 2018 financial results will be released on Wednesday, February 13, 2019 before the market opens.
The Company will host a conference call to discuss the financial results.
|Fourth Quarter 2018 Earnings Conference Call|
|When:||Wednesday, February 13, 2019 at 8:30 a.m. Eastern Time|
|Dial-in:||1-877-260-1479 for U.S.|
|1-334-323-0522 for International|
|Dial-in Replay:||1-888-203-1112 for U.S.|
|1-719-457-0820 for International|
|Available through Wednesday, February 20, 2019|
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. The company offers Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis and controlled substances. For more information, please visit www.cambrex.com.
|Investor Relations Associate|